BackAustralian Clinical Labs Limited Overview

Australian Clinical Labs Limited Goodwill

Latest goodwill for ACL.AX: $160M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$159.11M
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Australian Clinical Labs Limited Goodwill History

Loading

Australian Clinical Labs Limited vs. peers: Goodwill Comparison

Loading

Australian Clinical Labs Limited Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Australian Clinical Labs Limited (ACL.AX) FAQ

As of the most recent data (June 2026), ACL.AX shows a goodwill of $160M. That compares with $160M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACL.AX's goodwill is now $160M (was $160M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Australian Clinical Labs Limited is outperforming or lagging.

Tracking ACL.AX's goodwill over time shows whether Australian Clinical Labs Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $160M That compares with $160M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Australian Clinical Labs Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $160M) with ownership activity and broader fundamentals.